Cancer Research Articles

Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified medical oncologist Ahsan Shah, MD. He is seeing patients at the FCS Fort Myers Cancer Center at 8260 Gladiolus Drive, Fort Myers, FL and FCS Fort Myers Colonial office at 8931 Colonial Center Drive, Suite 300 in Fort Myers, FL.

Florida Cancer Specialists & Research Institute (FCS) welcomes medical oncologist and hematologist Kristen Gonter-Aubin, DO. She is seeing patients at the FCS Englewood office at 714 Doctors Drive, Englewood, FL. and at the FCS Venice Healthpark location at 836 Sunset Lake Blvd, Suite 101, Venice, FL.

Florida Cancer Specialists & Research Institute (FCS) is seeking to reduce deaths and suffering from hereditary cancers with the launch of a cancer genetics program across its statewide practice. The use of a powerful and proven technology tool developed by Chicago-based software and data analytics company, CancerIQ, and the addition of a specially-trained genetic professional will help identify patients whose cancer is linked to genetics and those at increased likelihood of developing cancer.

Florida Cancer Specialists & Research Institute (FCS), is pleased to announce that radiation oncologist, Kunal Saigal, MD will lead the new Sarasota Memorial Radiation Oncology Center, which opens August 3, 2020. The 18,000 square foot outpatient radiation center completes the first phase of the planned community Cancer Institute by Sarasota Memorial Health Care System (SMH), boasting two Varian TrueBeam linear accelerators, which are considered the gold standard for radiation oncology.

Florida Cancer Specialists & Research Institute (FCS), recently cut the ribbon on a new state-of-the-art facility at 1396 Whisper Circle, Sebring, FL to provide comprehensive treatments and a variety of services to adults with cancer and other diseases. The new location replaces the existing FCS clinic at 4420 Sun-N-Lake Blvd. in Sebring.

Florida Cancer Specialists & Research Institute (“FCS” or the “Company”), announced that FCS Chief Financial Officer Nathan H. Walcker has been named Chief Executive Officer, effective August 1, 2020. Walcker will succeed current Chief Executive Officer Brad Prechtl, MBA, who will retire from FCS, effective July 30, 2020, but continue to serve as a consultant through April 2021.

Lucio Gordan, MD, will lead an educational session at the Community Oncology Advocacy Summit Scheduled for July 15, 2020.

Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When complete in early 2021, the 37,000 square foot facility will include radiation oncology and next-generation PET/CT imaging technology along with 27 exam rooms and 52 chairs for chemotherapy and other infusions. Patients will also have access to participate in cutting-edge clinical trial research.